Please login to the form below

Not currently logged in
Email:
Password:

ADA meeting

This page shows the latest ADA meeting news and features for those working in and with pharma, biotech and healthcare.

J&J says real-world data finds no amputation risk for Invokana

J&J says real-world data finds no amputation risk for Invokana

Now, J&J has data from a patient registry involving more than 140, 000 type 2 diabetics treated with Invokana (canagliflozin) – reported at the American Diabetes Association (ADA) meeting in Orlando,

Latest news

  • Novo says real-world data backs its insulin switching Novo says real-world data backs its insulin switching

    The Danish drugmaker reported findings from its EU-TREAT patient registry study at the American Diabetes Association (ADA) meeting in San Diego on Saturday. ... Top-line data from that trial was reported late last month and will be presented as a keynote

  • IBM plans Watson-powered 'diabetes advisor' IBM plans Watson-powered 'diabetes advisor'

    The collaboration will marry IBM's Watson supercomputer with the vast repository of clinical and research data held by the ADA. ... Announcing the tie-up at the ADA's annual scientific meeting earlier this month, IBM and the ADA also outlined their plans

  • Rivals look to put pressure on Sanofi's Lantus Rivals look to put pressure on Sanofi's Lantus

    Novo Nordisk and Lilly claim clinical benefitsover top-selling diabetes drug.  . The American Diabetes Association's (ADA) Scientific Sessions meeting in Boston this weekend saw several of Sanofi's rivals claim ... of patients reaching the ADA's target

  • Relief as study finds no cardiovascular risk with Januvia Relief as study finds no cardiovascular risk with Januvia

    The data will be scrutinised further when presented at the American Diabetes Association (ADA) meeting in Boston in June, but analysts suggested the results could help Januvia consolidate its position as

  • AZ and Takeda drugs should carry heart failure warning AZ and Takeda drugs should carry heart failure warning

    With that in mind, attention is fixed on the forthcoming results from the TECOS trial of Januvia, which are due to be presented at the American Diabetes Association (ADA) meeting in

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics